HIGHLIGHTS
- who: Top from the School of Pharmaceutical Sciences, Zhengzhou University, Henan Province, Zhengzhou, China have published the paper: responsive Fe liberating and artemisinin delivery, in the Journal: (JOURNAL)
- what: In this study a visible lightsensitive nanoplatform (HA-TiO2-IONPs/ART) was developed. Next, in_vitro and in_vivo experiments were carried out to evaluate the anti-tumor effect.
- how: This result was consistent with Photocatalytic activity suggesting that HA-TiO2-IONPs could be acted as both drug vehicle and photosensitizer for tumor photodynamic therapy. The authors carried out pharmacokinetics experiment to study prolonged circulation of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.